Former Naurex execs launch Aptinyx

A team of former Naurex Inc. executives have spun out the company's discovery platform and preclinical pipeline into Aptinyx Inc. (Evanston, Ill.), a newco focused on developing treatments for psychiatric and neurologic disorders.

Aptinyx President and CEO Norbert Riedel said all of Naurex's shareholders contributed an undisclosed amount of seed funding for Aptinyx as part of Naurex's acquisition by Allergan plc (NYSE:AGN) last month. Riedel was Naurex's CEO (see BioCentury Extra, July 27). ...